LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.55 | 771.67 | 6129 | 6829 | 0.8974 | 0.9323 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 771.67 | 6514 | 7256 | 0.8977 | 0.9343 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 771.67 | 6514 | 7256 | 0.8977 | 0.9343 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.99 | 771.67 | 6811 | 7690 | 0.8857 | 0.9281 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.99 | 771.67 | 6915 | 7690 | 0.8992 | 0.9370 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.21 | 771.67 | 7046 | 8085 | 0.8714 | 0.9204 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.21 | 771.67 | 7257 | 8085 | 0.8975 | 0.9372 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.44 | 771.67 | 7184 | 8530 | 0.8421 | 0.9033 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.44 | 771.67 | 7632 | 8530 | 0.8947 | 0.9368 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.66 | 771.67 | 7412 | 8978 | 0.8255 | 0.8946 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.66 | 771.67 | 8040 | 8978 | 0.8955 | 0.9386 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.88 | 771.67 | 7631 | 9447 | 0.8078 | 0.8853 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.88 | 771.67 | 8384 | 9447 | 0.8875 | 0.9350 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.10 | 771.67 | 7778 | 9800 | 0.7937 | 0.8778 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.10 | 771.67 | 8780 | 9800 | 0.8959 | 0.9409 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.32 | 771.67 | 7953 | 10212 | 0.7788 | 0.8702 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.32 | 771.67 | 9041 | 10212 | 0.8853 | 0.9357 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.54 | 771.67 | 8132 | 10532 | 0.7721 | 0.8674 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 71.54 | 771.67 | 9374 | 10532 | 0.8900 | 0.9391 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.76 | 771.67 | 8171 | 10851 | 0.7530 | 0.8566 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 73.76 | 771.67 | 9564 | 10851 | 0.8813 | 0.9348 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.02 | 771.67 | 8335 | 11106 | 0.7504 | 0.8562 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.02 | 771.67 | 9960 | 11106 | 0.8968 | 0.9441 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.25 | 771.67 | 8414 | 11367 | 0.7402 | 0.8508 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.25 | 771.67 | 10232 | 11367 | 0.9001 | 0.9465 | MN20160304_L01 | G16 |